KAREN WUNDERLICH: Open Payments
NPI 1710963483 · NEW MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 39 payments from 12 companies in 2025. Trend: 2023 $1,394 · 2024 $861 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 8 | $198 |
| MILLICENT US INC | 7 | $150 |
| Sumitomo Pharma America, Inc. | 5 | $120 |
| Astellas Pharma US Inc | 3 | $98 |
| Aspira Women's Health Inc | 2 | $98 |
| Amgen Inc. | 5 | $97 |
| Exact Sciences Corporation | 2 | $61 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| CooperSurgical, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: MYFEMBREE, Veozah, OVA1, EVENITY, FEMLYV, FEMRING, GARDASIL 9, Paragard T 380A.
Industry payments across CT — which companies pay providers there.
